W. M. Smit

753 total citations
16 papers, 546 citations indexed

About

W. M. Smit is a scholar working on Genetics, Oncology and Hematology. According to data from OpenAlex, W. M. Smit has authored 16 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Oncology and 5 papers in Hematology. Recurrent topics in W. M. Smit's work include Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and HER2/EGFR in Cancer Research (3 papers). W. M. Smit is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and HER2/EGFR in Cancer Research (3 papers). W. M. Smit collaborates with scholars based in Netherlands, United States and Gabon. W. M. Smit's co-authors include Cornelia F. van Uden–Kraan, Mart A F J van de Laar, Erik Taal, Constance H.C. Drossaert, E.R. Seydel, Hein J. Bernelot Moens, Sabine Siesling, Jan H.M. Schellens, Elisabeth G.E. de Vries and M. Nooij and has published in prestigious journals such as Blood, Clinical Cancer Research and Computers in Human Behavior.

In The Last Decade

W. M. Smit

16 papers receiving 530 citations

Peers

W. M. Smit
Mamta Kalidas United States
J. Leonard Lichtenfeld United States
Jan Geißler United Kingdom
Kate A. McBride Australia
Enrique Davila United States
Suzanne Cole United States
Harumi Yamamoto Japan
Archana Radhakrishnan United States
Anne‐Gaëlle Le Corroller France
Valentin Barsan United States
Mamta Kalidas United States
W. M. Smit
Citations per year, relative to W. M. Smit W. M. Smit (= 1×) peers Mamta Kalidas

Countries citing papers authored by W. M. Smit

Since Specialization
Citations

This map shows the geographic impact of W. M. Smit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. M. Smit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. M. Smit more than expected).

Fields of papers citing papers by W. M. Smit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. M. Smit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. M. Smit. The network helps show where W. M. Smit may publish in the future.

Co-authorship network of co-authors of W. M. Smit

This figure shows the co-authorship network connecting the top 25 collaborators of W. M. Smit. A scholar is included among the top collaborators of W. M. Smit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. M. Smit. W. M. Smit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Blijlevens, Nicole M. A., Saskia K. Klein, W. M. Smit, et al.. (2022). P709: CLINICAL OUTCOME OF ASCIMINIB TREATMENT IN A REAL-WORLD MULTI-RESISTANT CML PATIENT POPULATION.. HemaSphere. 6. 604–605. 6 indexed citations
2.
Rombout‐Sestrienkova, Eva, Nicolaas de Jonge, C. Klöpping, et al.. (2014). End-Stage Cardiomyopathy Because of Hereditary Hemochromatosis Successfully Treated With Erythrocytapheresis in Combination With Left Ventricular Assist Device Support. Circulation Heart Failure. 7(3). 541–543. 10 indexed citations
3.
Kroep, Judith R., Sabine C. Linn, Epie Boven, et al.. (2010). Lapatinib: clinical benefit in patients with HER 2-positive advanced breast cancer.. PubMed. 68(9). 371–6. 13 indexed citations
4.
Uden–Kraan, Cornelia F. van, Constance H.C. Drossaert, Erik Taal, et al.. (2010). Experiences and attitudes of Dutch rheumatologists and oncologists with regard to their patients’ health-related Internet use. Clinical Rheumatology. 29(11). 1229–1236. 27 indexed citations
5.
Uden–Kraan, Cornelia F. van, Constance H.C. Drossaert, Erik Taal, et al.. (2009). Health-related Internet use by patients with somatic diseases: Frequency of use and characteristics of users. Informatics for Health and Social Care. 34(1). 18–29. 84 indexed citations
6.
Deenik, Wendy, Jeroen J. W. M. Janssen, Bronno van der Holt, et al.. (2009). Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia. Haematologica. 95(6). 914–921. 19 indexed citations
7.
Nieboer, Peter, Elisabeth G.E. de Vries, Nanno H. Mulder, et al.. (2008). Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients. Bone Marrow Transplantation. 42(7). 475–481. 9 indexed citations
8.
Uden–Kraan, Cornelia F. van, Constance H.C. Drossaert, Erik Taal, et al.. (2007). Coping with somatic illnesses in online support groups: Do the feared disadvantages actually occur?. Computers in Human Behavior. 24(2). 309–324. 75 indexed citations
9.
Hannemann, Juliane, Petra Kristel, Harm van Tinteren, et al.. (2006). Molecular subtypes of breast cancer and amplification of topoisomerase IIα: predictive role in dose intensive adjuvant chemotherapy. British Journal of Cancer. 95(10). 1334–1341. 54 indexed citations
10.
Rodenhuis, Sjoerd, M. Bontenbal, Q.G.C.M. van Hoesel, et al.. (2006). Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer. Annals of Oncology. 17(4). 588–596. 57 indexed citations
11.
Bosch, Tessa M., Alwin D. R. Huitema, Valerie D. Doodeman, et al.. (2006). Pharmacogenetic Screening of CYP3A and ABCB1 in Relation to Population Pharmacokinetics of Docetaxel. Clinical Cancer Research. 12(19). 5786–5793. 107 indexed citations
12.
Franke, H., et al.. (2005). Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy. Gynecological Endocrinology. 20(5). 274–278. 22 indexed citations
13.
14.
Posthuma, Eduardus F. M., Erik W.A. Marijt, Renée M. Y. Barge, et al.. (2004). α-Interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease. Biology of Blood and Marrow Transplantation. 10(3). 204–212. 36 indexed citations
15.
Groot, Marco R. de, et al.. (2004). [Pregnancy and chemotherapy; an apparent contradiction].. PubMed. 148(8). 349–52. 3 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mamta Kalidas Breakdown of academic impact, for papers by J. Leonard Lichtenfeld Breakdown of academic impact, for papers by Jan Geißler Breakdown of academic impact, for papers by Kate A. McBride Breakdown of academic impact, for papers by Enrique Davila Breakdown of academic impact, for papers by Suzanne Cole Breakdown of academic impact, for papers by Harumi Yamamoto Breakdown of academic impact, for papers by Archana Radhakrishnan Breakdown of academic impact, for papers by Anne‐Gaëlle Le Corroller Breakdown of academic impact, for papers by Valentin Barsan
Rankless by CCL
2026